Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Acknowledgement to Contributors56
Acknowledgement to Reviewers52
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy34
ZNF146-Mediated HMGB1-NF-κB Signaling Activation as a Therapeutic Target and Prognostic Biomarker in Osteosarcoma31
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration20
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
Research Progress on the Anticancer Activity of Plant Polysaccharides18
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway18
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer17
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review17
Protective Assessment of Novel (BNC Formulation) against Brain Tumor17
Patent Selections17
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review15
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents15
The Present State and Potential Applications of Artificial Intelligence in Cancer Diagnosis and Treatment14
Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway14
Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma with Radiotherapy Interruptions: A Lesson Learned from the Lockdown Due to COVID-1914
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer14
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment14
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer14
0.50679993629456